Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| 3M | INDUSTRY |
Surgical skin complications can be costly and could contribute to extended in-patient stay following total joint replacement or even the need for re-admission. If efficacy in reducing the incidence of post-operative wound drainage and, in turn, surgical wound complications can be demonstrated, it may also reduce the length of hospital stay and the need for revision surgery or readmission. The aim of this research is to investigate the incidence of post-operative wound drainage following elective total joint arthroplasty using two surgical skin preparation protocols.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Standard surgical skin preparation | No Intervention | ||
| Standard Surgical Skin Preparation with Duraprep | Active Comparator | standard surgical skin prep |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Duraprep Surgical Solution | Drug |
|
| Measure | Description | Time Frame |
|---|---|---|
| The primary objective of this study is to determine the rate of wound drainage following total joint arthroplasty (TJA) until discharge in both treatment groups | Starting on post operative day 1 (the first day following surgery), at the time of the surgical dressings are removed and changed, assessments will be made to determine level of post-operative wound drainage following TJA. | Up to one year following surgery |
| Measure | Description | Time Frame |
|---|---|---|
| The secondary objectives will focus on wound assessment and signs and symptoms of infection from TJA until discharge. | until hospital discharge | |
| Length of hospital stay | until hospital discharge |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Javad Parvizi, MD, FRCS | Rothman Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Rothman Institute | Philadelphia | Pennsylvania | 19107 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
| Need for readmission or reoperation for up to 6 weeks following TJA | 6 weeks post-op |
| Incidence of surgical skin infection at the first post-operative visit (6 weeks following surgery) | 6 weeks post-op |
| Incidence of skin blistering. | up to one year post-op |
| Scar cosmesis at the first post-operative visit. | up to 6 weeks post-op |